Science
Mechanism of Action
This ingredient functions as a targeted serine protease inhibitor, specifically modulating the overactivity of urokinase and plasmin in the epidermis. By inhibiting these enzymes, it prevents the premature degradation of corneodesmosomes—specifically Desmoglein 1—while simultaneously upregulating the production of essential barrier proteins like loricrin and transglutaminase-1 to physically reinforce the skin's architecture.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 In vivo testing at 1% concentration demonstrated a 16% reduction in transepidermal water loss (TEWL) on dry cheek skin within 7 days.
- 02 In vitro data shows up to 97% inhibition of urokinase activity and a 41% reduction in plasmin activity, critical for preventing barrier breakdown.
- 03 Clinical microbiome analysis confirmed a shift toward healthy skin flora, specifically increasing Staphylococcus epidermidis while reducing populations of Corynebacterium kroppenstedtii.
Transparency
Dusting Analysis
As a high-tech trade name peptide (SYN-UP), this ingredient is often included at sub-clinical levels for label claims. Formulations containing significantly less than 1% of the trade name solution may not deliver the measured 16% barrier improvement or microbiome-balancing benefits.
The Formula
Formulation
Stability
Maintains high stability across a broad pH range, with peak biological activity observed at pH 6.0. It is typically supplied in a glycerin-water base for easier integration.
Synergies
- Glycerin
- Barrier-identical lipids
- Niacinamide
Conflicts
- Strong oxidizing agents
- Proteolytic enzymes
- Formulations with pH below 3.0 or above 8.0
Safety
Safety Profile
Recognized as a safe skin-conditioning agent in the EU CosIng and PCPC databases; it is notably effective at reducing sensory irritation (stinging) in sensitive skin types.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional biotech peptide for those requiring pharmaceutical-grade barrier reinforcement and microbiome stabilization, provided it is used at the 1% clinical threshold.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources